These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 18598919)
1. Present perspectives on flaviviral chemotherapy. Ghosh D; Basu A Drug Discov Today; 2008 Jul; 13(13-14):619-24. PubMed ID: 18598919 [TBL] [Abstract][Full Text] [Related]
2. Rodent models for the study of therapy against flavivirus infections. Charlier N; Leyssen P; De Clercq E; Neyts J Antiviral Res; 2004 Aug; 63(2):67-77. PubMed ID: 15321702 [TBL] [Abstract][Full Text] [Related]
3. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs. Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379 [TBL] [Abstract][Full Text] [Related]
4. Mouse and hamster models for the study of therapy against flavivirus infections. Charlier N; De Clercq E; Neyts J Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165 [TBL] [Abstract][Full Text] [Related]
5. A novel model for the study of the therapy of flavivirus infections using the Modoc virus. Leyssen P; Van Lommel A ; Drosten C; Schmitz H; De Clercq E ; Neyts J Virology; 2001 Jan; 279(1):27-37. PubMed ID: 11145886 [TBL] [Abstract][Full Text] [Related]
6. Finding new medicines for flaviviral targets. Keller TH; Chen YL; Knox JE; Lim SP; Ma NL; Patel SJ; Sampath A; Wang QY; Yin Z; Vasudevan SG Novartis Found Symp; 2006; 277():102-14; discussion 114-9, 251-3. PubMed ID: 17319157 [TBL] [Abstract][Full Text] [Related]
11. Molecular targets for flavivirus drug discovery. Sampath A; Padmanabhan R Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313 [TBL] [Abstract][Full Text] [Related]
12. Development of novel antivirals against flaviviruses. Patkar CG; Kuhn RJ Novartis Found Symp; 2006; 277():41-52; discussion 52-6, 71-3, 251-3. PubMed ID: 17319153 [TBL] [Abstract][Full Text] [Related]
13. The importance of viral and cellular factors on flavivirus entry. Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540 [TBL] [Abstract][Full Text] [Related]
14. [The Alkhurma virus (family Flaviviridae, genus Flavivirus): an emerging pathogen responsible for hemorrhage fever in the Middle East]. Charrel RN; de Lamballerie X Med Trop (Mars); 2003; 63(3):296-9. PubMed ID: 14579470 [TBL] [Abstract][Full Text] [Related]
15. Review of Phytochemical Compounds as Antiviral Agents Against Arboviruses from the Genera Flavivirus and Alphavirus. Sardari S; Rafieian-Kopaei M; Malekmohammad K; Sewell RDE Curr Drug Discov Technol; 2020; 17(4):484-497. PubMed ID: 31969106 [TBL] [Abstract][Full Text] [Related]
16. [New approaches to the treatment of the flavivirus infections]. Morozova OV; Isaeva EI; Viazov SO Vopr Virusol; 2015; 60(6):5-9. PubMed ID: 27024909 [TBL] [Abstract][Full Text] [Related]
17. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses. Eyer L; Nencka R; de Clercq E; Seley-Radtke K; Růžek D Antivir Chem Chemother; 2018; 26():2040206618761299. PubMed ID: 29534608 [TBL] [Abstract][Full Text] [Related]
18. The flavivirus capsid protein: Structure, function and perspectives towards drug design. Oliveira ERA; Mohana-Borges R; de Alencastro RB; Horta BAC Virus Res; 2017 Jan; 227():115-123. PubMed ID: 27751882 [TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Lee E; Pavy M; Young N; Freeman C; Lobigs M Antiviral Res; 2006 Jan; 69(1):31-8. PubMed ID: 16309754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]